HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ethanol-mediated suppression of IL-37 licenses alcoholic liver disease.

AbstractBACKGROUND & AIMS:
Chronic alcohol consumption and alcoholic liver disease (ALD) afflicts individuals with substantial morbidity and mortality with limited treatment options available. Hepatic inflammation, triggered by activated Kupffer cells, is a driving force in alcoholic liver disease. Interleukin 37 (IL-37) exerts anti-inflammatory effects in hepatic diseases, however, the impact of Interleukin 37 on alcoholic liver disease is unknown. In this study, we addressed the role of Interleukin 37 in alcoholic liver disease.
METHODS:
We utilized Interleukin 37 expressing transgenic mice and human recombinant Interleukin 37 in models of alcoholic liver disease. Interleukin 37 expression was measured in liver samples of 20 alcoholic steatohepatitis and 36 non-alcoholic fatty liver disease patients.
RESULTS:
Interleukin 37 transgenic mice are not protected against hepatic injury and inflammation in alcoholic liver disease. Ethanol suppressed Interleukin 37 expression in transgenic mice. Alcoholic steatohepatitis (ASH) patients similarly exhibited reduced Interleukin 37 expression when compared to non-alcoholic fatty liver disease (NAFLD) patients. Human recombinant Interleukin 37 ameliorated hepatic inflammation in a binge drinking model of alcoholic liver disease.
CONCLUSION:
We provide evidence for an exogenous noxae that suppresses Interleukin 37 expression which limits its anti-inflammatory effects in alcoholic liver disease.
AuthorsFelix Grabherr, Christoph Grander, Timon E Adolph, Verena Wieser, Lisa Mayr, Barbara Enrich, Sophie Macheiner, Moris Sangineto, Andreas Reiter, Andre Viveiros, Heinz Zoller, Philip Bufler, Alexander R Moschen, Charles A Dinarello, Herbert Tilg
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 38 Issue 6 Pg. 1095-1101 (06 2018) ISSN: 1478-3231 [Electronic] United States
PMID29193575 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • IL37 protein, human
  • Interleukin-1
  • RNA, Messenger
  • Ethanol
Topics
  • Adult
  • Aged
  • Alcohol Drinking (adverse effects)
  • Animals
  • Ethanol (administration & dosage, adverse effects)
  • Female
  • Humans
  • Interleukin-1 (metabolism)
  • Liver (metabolism, pathology)
  • Liver Diseases, Alcoholic (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease (metabolism)
  • RNA, Messenger (analysis)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: